Everolimus-Based Therapy versus Chemotherapy among Patients with HR+/HER2− Metastatic Breast Cancer: Comparative Effectiveness from a Chart Review Study

Objective. To compare the real-world effectiveness of everolimus-based therapy and chemotherapy in postmenopausal women with hormone-receptor-positive/human-epidermal-growth-factor-receptor-2-negative (HR+/HER2−) metastatic breast cancer (mBC). Methods. This retrospective chart review examined a nat...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Nanxin, Hao, Yanni, Xie, Jipan, Lin, Peggy L., Koo, Valerie, Ohashi, Erika, Wu, Eric Q.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2015
Materias:
Clinical Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4452841/
https://www.ncbi.nlm.nih.gov/pubmed/26078883
http://dx.doi.org/10.1155/2015/240750

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4452841/
https://www.ncbi.nlm.nih.gov/pubmed/26078883
http://dx.doi.org/10.1155/2015/240750

Ejemplares similares